Bionano Genomics, Inc BNGO 深 滬
等待開盤 09-06 09:30:00 美东时间
3.99
+0.350
+9.62%
華盛通- 最 高3.995
- 今 開3.69
- 成交量 9.03万股
- 最 低 3.66
- 昨 收 3.64
- 總市值 1867.72万
- 52周最高 30.516
- 市盈率 靜 --
- 換手率 1.93%
- 52周最低 2.68
- 委 比 26.99%
- 總股本 468.10万
- 歷史最高 9414.00
- 量 比 0.56
- 振 幅 9.20%
- 歷史最低 3.66
- 每 手 1
- 風險率 7.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Bionano Genomics Selected For Sole Source Contract By NIH For Optical Genome Mapping Reagents And Instruments; No Contract Value Disclosed
https://sam.gov/opp/7a19a6e8954c4de1a128b841e2018400/view DescriptionThis is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.This
09-02 23:43
Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Bionano Genomics, Inc. announced that its CEO, Erik Holmlin, will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, at 3:00 p.m. ET. The presentation will be available via webcast and replay through Bionano's website for 30 days.
08-25 12:00
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Raises Price Target to $11
HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and raises the price target from $10 to $11.
08-18 19:27
Bionano Genomics Q2 EPS $(1.99) Beats $(2.42) Estimate, Sales $6.733M Miss $6.832M Estimate
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.99) per share which beat the analyst consensus estimate of $(2.42) by 17.6 percent. This is a 86.18 percent increase over losses of $(14.40) per share from
08-15 04:34
Bionano Genomics Sees Q3 Sales $6.700M-$7.200M vs $7.661M Est
Bionano Genomics (NASDAQ:BNGO) sees Q3 sales of $6.700 million-$7.200 million vs $7.661 million analyst estimate.
08-15 04:04
Earnings Scheduled For August 14, 2025
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
A Preview Of Bionano Genomics's Earnings
Bionano Genomics (NASDAQ:BNGO) is set to give its latest quarterly earnings rep...
08-14 02:02
Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL
<p>Bionano Genomics announced a study using optical genome mapping (OGM) to detect oncogenic structural variants in infant and toddler T-ALL. OGM identified distinct genetic drivers and prognostic subgroups in a retrospective analysis of 27 cases, revealing NKX2 rearrangements in one-third of cases and distinct genomic profiles compared to older patients. Despite aggressive presentations, survival rates were comparable between age groups. OGM's s...
08-07 12:00
Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference
Bionano Genomics的CEO Erik Holmlin将于8月13日在Canaccord Genuity的年度会议上发表演讲，会议时间为下午3:00至3:25 ET。演讲可通过提供的链接注册观看，会议录音将在Bionano网站上保留至少30天。Bionano专注于提供基因组分析解决方案，包括光学基因组图谱技术、诊断服务和软件，以帮助研究人员和临床医生解答生物学和医学难题。
08-06 12:00
Bionano Announces Upgrades to its Software and Compute Platforms to Make Analysis of OGM, Microarray and NGS Data Easier, Faster and More Accurate
Bionano Genomics announces the release of VIA 7.2 and Solve 3.8.3 software, alongside Stratys Compute server upgrades. VIA 7.2 introduces AI for faster OGM data analysis, lab history learning, SAP scoring for OGM variants, and standard nomenclature alignment. Solve 3.8.3 expands SV database by 18% and enhances detection performance. Stratys Compute upgrades double weekly cancer sample analysis capacity and expand functionality. These updates aim ...
08-05 12:00
